Nicodicodeine
![]() | |
![]() | |
Clinical data | |
---|---|
Synonyms | 6-Nicotinoyldihydrocodeine |
Routes of administration | Oral, intravenous |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ECHA InfoCard |
100.011.241 ![]() |
Chemical and physical data | |
Formula | C24H26N2O4 |
Molar mass | 406.474 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
Nicodicodeine is an opioid developed as a cough suppressant and analgesic. Synthesized in 1904, it is not commonly used, but has activity similar to other opioids. Nicodicodeine is metabolised in the liver by demethylation to produce 6-nicotinoyldihydromorphine, and subsequently further metabolised to dihydromorphine. Since the final active metabolite is the slightly stronger opiate dihydromorphine rather than morphine, nicodicodeine can be expected to be marginally more potent and longer acting than nicocodeine. Side effects are similar to those of other opioids and include itching, nausea and respiratory depression.
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.